dopaminergic agent

出典: meddic


Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2015/04/23 15:01:04」(JST)

wiki en

[Wiki en表示]

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.


  • Dopamine is a safe antiangiogenic drug which can also prevent 5-fluorouracil induced neutropenia.
  • Sarkar C1, Chakroborty D1, Dasgupta PS2, Basu S1,3.
  • International journal of cancer. Journal international du cancer.Int J Cancer.2015 Aug 1;137(3):744-9. doi: 10.1002/ijc.29414. Epub 2015 Jan 7.
  • The role of vascular endothelial growth factor A (VEGFA) in tumor angiogenesis is well established and accordingly, molecules targeting VEGFA or its receptors are being presently used in the clinics for treatment of several types of cancer. However, these antiangiogenic agents are expensive and have
  • PMID 25556636
  • Antagonistic pleiotropic effects of nitric oxide in the pathophysiology of Parkinson's disease.
  • Tripathy D1, Chakraborty J, Mohanakumar KP.
  • Free radical research.Free Radic Res.2015 Jun 4:1-11. [Epub ahead of print]
  • Sporadic Parkinson's disease (PD) is a geriatric disorder with unknown etiology, specifically affecting the nigrostriatal dopaminergic (DA-ergic) pathway of the brain. Amongst several contributing factors, nitric oxide (NO•) is considered to inflict injury to DA-ergic neurons, and to influence PD
  • PMID 25968946
  • Pharmacologic Treatment of Type 2 Diabetes: Injectable Medications.
  • Tran L1, Zielinski A2, Roach AH2, Jende JA2, Householder AM2, Cole EE2, Atway SA2, Amornyard M2, Accursi ML2, Shieh SW2, Thompson EE2.
  • The Annals of pharmacotherapy.Ann Pharmacother.2015 Jun;49(6):700-714. Epub 2015 Mar 23.
  • OBJECTIVE: To review the oral and injectable pharmacologic treatment options for type 2 diabetes.DATA SOURCES: A literature search was conducted using PubMed electronic database for studies published in English between 1993 and September 2014. Search terms included diabetes mellitus, type 2 diabetes
  • PMID 25802244


  • Pharmacokinetics and Brain Distribution of Tetrahydropalmatine and Tetrahydroberberine after Oral Administration of DA-9701, a New Botanical Gastroprokinetic Agent, in Rats
  • , , [他], ,
  • Biological and Pharmaceutical Bulletin 38(2), 285-291, 2015
  • … DA-9701, a new botanical gastroprokinetic agent, has potential for the management of delayed gastric emptying in Parkinson's disease if it has no central anti-dopaminergic activity. …
  • NAID 130004872260
  • CBSにおける画像診断
  • 篠遠 仁
  • 臨床神経学 53(11), 1029-1032, 2013
  • 最近,大脳皮質基底核変性症(CBD)および症候群(CBS)の背景病理と生前のMRIにおける脳萎縮分布との対応を検討した報告がいくつかある.CBD群では健常対照群と比較して背側前頭前野,中心溝近傍,線条体,脳幹において萎縮がみられ,左右差がめだつ症例は多くはなかった.CBSでは背景病理にかかわらず中心溝周辺の萎縮がみられ,前頭側頭葉変性症(CBS-FTDL)ではそれに加えて前頭前野,線条体,脳幹に萎 …
  • NAID 130004505326
  • Mithramycin, an Agent for Developing New Therapeutic Drugs for Neurodegenerative Diseases
  • , , [他],
  • Journal of Pharmacological Sciences 122(4), 251-256, 2013
  • … MTM has been shown to prolong the survival of Huntington's disease model mice and to attenuate dopaminergic neurotoxicity in mice after repeated administration of methamphetamine. … In this review, we provide an up to date overview of neuroprotective effects of MTM and less toxic MTM analogs, MTM SK and MTM SDK, on some of the neurodegenerative diseases and discuss the promise of MTM as an agent for developing new therapeutic drugs for such diseases. …
  • NAID 130003362729


Dopamine releasing agents (DRAs) such as amphetamine (Adderall, Dexedrine; "Speed"), lisdexamfetamine (Vyvanse), methamphetamine (Desoxyn; "Meth", " Crank", "Crystal", etc), ...



リンク元ドパミン作動薬」「ドパミン系薬物」「ドーパミン系薬物」「dopamine agent



dopamine agonistdopaminergic agonistdopaminergic agent, dopaminergic drug, dopamine receptor agonist, dopamine receptor stimulant
[show details]
  • ドパミン作動薬:レボドパ、ブロモクリプチン、インスリン、アルギニン、グルカゴン、プロプラノール(QB.D-254)



dopaminergic agentdopaminergic drugdopamine agent



dopaminergic agentdopaminergic drug

dopamine agent」


dopaminergic agentdopaminergic drug



  • n.
  • 代行者、代理人。代理業者
  • 政府職員、官吏
  • ある後位をする人、ある作用をするもの。動員、動力因、作用因。(文法)動作主。科学的変化を起こさせるもの、薬品、~剤。病原体
agonistagonisticattorneydelegatedrugetiologic agentfomesfomitesmediatorpathogenpathogenicpharmaceutical preparationvectorvehicle

WordNet   license wordnet

「a substance that exerts some force or effect」

WordNet   license wordnet

「a businessman who buys or sells for another in exchange for a commission」
factor, broker

WordNet   license wordnet

「any agent or representative of a federal agency or bureau」
federal agent

WordNet   license wordnet

「a representative who acts on behalf of other persons or organizations」

WordNet   license wordnet

「an active and efficient cause; capable of producing a certain effect; "their research uncovered new disease agents"」

PrepTutorEJDIC   license prepejdic

「『代理人』;周旋人 / 働き(作用)を起こすもの;作用物,薬剤 / (政府機関,特にFBI,CIAなどの)部員,機関員」



  • n.
  • v.
  • 加齢する、熟成する
agedageingagingyear old

WordNet   license wordnet

「how long something has existed; "it was replaced because of its age"」

WordNet   license wordnet

「a time of life (usually defined in years) at which some particular qualification or power arises; "she was now of school age"; "tall for his eld"」

WordNet   license wordnet

「begin to seem older; get older; "The death of his wife caused him to age fast"」

WordNet   license wordnet

「make older; "The death of his child aged him tremendously"」

PrepTutorEJDIC   license prepejdic

「〈U〉(一般に)『年齢』,寿命;〈C〉(個々の)『年齢』,年 / 〈U〉成年(おとなとしての資格・権利を得る年齢;通例18または21歳) / 〈U〉『老齢』;《集合的に》老人たち / 〈U〉(人生の)『一時期』;〈C〉世代(generation) / 〈U〉〈C〉《しばしばA-》(歴史上の)『時代』 / 〈C〉《話》長い間 / 年をとる,ふける;〈物が〉古くなる / 〈年〉'を'とらせる;〈物〉'を'古びさせる」



  • adj.
  • ドパミン作動性の、ドーパミン作動性の、ドパミン系の、ドーパミン系の